公司資料
Emergent BioSolutions 股價、新聞與催化劑
- 股票代碼:
- EBS
- 交易所:
- NYSE
- 產業:
- Biopharma
- 所在地:
- United States
股票表現
4.82 USD (-1.43%)
收盤價
最後更新: 2026年8月20日
424M USD
市值
股價為何變動
As of Aug 20, 2026, EBS closed down 1.43% at $4.82. No new same-company headline was identified in the current news window.
公司概覽
業務概覽
Emergent BioSolutions is a biodefense and specialty products company focused on public-health preparedness, vaccines, and medical countermeasures. Its business is centered on government and specialty healthcare contracts.
所在地與產業分類
Headquartered in the United States and listed on NYSE, Emergent sits in specialty healthcare and biodefense.
商業模式特徵
The company depends on government contracts, product supply, and the execution of its public-health franchise.
生技產業定位
Emergent is outside biotech proper and belongs to the biodefense and specialty-products layer.
未來催化劑
- Emergent BioSolutions’ catalysts are biodefense contract awards, manufacturing execution, and any update on its public-health products. The market will care about whether the company can keep its federal-defense and infectious-disease franchise stable.
近期新聞
- 01
- 02
- 03
- 04
- 05
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。